USPTO serial 79198074
OURLOOP
Reviewed by CopyMark Law Group
Reg. 5537615Status 709
- Filing date
- Status date
- Registration date
- Aug 14, 2018
- Examiner
- HENRY, NAKIA D
- Law office
- TMO LAW OFFICE 129 - EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with OURLOOP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, cognitive impairment, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, cancer, pain, alcoholism and dependency; diagnostic preparations, substances, reagents and agents for medical purposes; pharmaceuticals for treatment of cognitive disorders | SECTION 71 - CANCELLED | — |
| 009 | Downloadable electronic publications in the nature of books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of clinical, medical, pharmaceutical or clinical or medical diagnostic research and development, clinical tests, clinical or medical diagnostic, medicine, pharmaceuticals, medical disorders, medical diseases, clinical or medical treatment and prevention; application software for mobile devices for clinical or medical diagnostic purposes relating to mental or behavioral health; downloadable electronic publications in the nature of brochures, books, magazines related to assessment of cognitive functions; applications software for mobile devices for assessment of cognitive functions; downloadable software for assessment of cognitive functions; software application for measuring psychical and mental health; software used as an installation tool for software applications to retrieve data which is sent automatically | SECTION 71 - CANCELLED | — |
| 010 | Surgical and medical apparatus and instruments; diagnostic apparatus and instruments for medical purposes for monitoring patient behavior and medication compliance; integrated medical systems containing medical instruments and software for information and information management for use of a Web-based physical and psychological and neurological examination and assessment of patients and clients at a distance and at a clinic; medical instruments for information, guidance and control of medicines | SECTION 71 - CANCELLED | — |
| 041 | Education in the nature classes, seminars, workshops in the field of clinical, medical, pharmaceutical and medical diagnostic research and development; providing of training in the form of courses, seminars, workshops in the field of clinical, medical, pharmaceutical and medical diagnostic research and development; arranging and conducting seminars, conferences, symposiums, workshops and courses in the field of clinical, medical, pharmaceutical and medical diagnostic research and development; educational services in the nature of classes, seminars, and workshops, and training services in the field of research and development, science, clinical tests, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention related to assessment of cognitive functions; providing the aforementioned services electronically, on-line, via Internet or other electronic media; arranging and conducting expert in person educational forums in the field of clinical, medical, pharmaceutical and medical diagnostic research and development; on-line training programs in the form of courses, seminars, workshops in the field of research and development, science, clinical tests, diagnostic medicine, pharmaceuticals, and with regard to disorders, diseases, treatment and prevention related to assessment of cognitive functions; providing on-line, non-downloadable publications, namely, books, reports, brochures, booklets, patient information leaflets, magazines, journals, teaching and educational material in the field of research and development, science, clinical tests, diagnostic medicine, pharmaceuticals with regard to disorders, diseases, treatment and prevention related to assessment of cognitive functions | SECTION 71 - CANCELLED | — |
| 042 | Pharmaceutical research and development; scientific and technological services, namely, research in the field of medical disorders, medical diseases and medical treatment; scientific and technological services, namely, research in the field of the central nervous system and related disorders, diseases and pharmaceuticals related thereto; medical research and tests in the field of assessment of cognitive functions for mental or behavioral ill health; clinical research and tests in the field of the assessment of cognitive functions; providing online non-downloadable screening software for assessment of cognitive functions | SECTION 71 - CANCELLED | — |
| 044 | Medical and healthcare services, namely, providing medical clinics providing assessment of cognitive functions and therapeutic services, namely, the treatment of cognitive disorders and diseases; medical services in the field of psychiatry and psychology and diagnosis and treatment of central nervous system diseases and disorders; medical advice related to medical and pharmaceutical preparations and substances; healthcare and medical services related to central nervous system and brain disorders; providing medical and medicinal information in the field of diagnostics, pharmaceuticals, disorders, diseases, treatment and prevention; providing on-line medical data and analyses designed to provide patients with customized information, including information regarding medical dose, diagnosis, therapeutic issues; remote monitoring of data relating to patients health and diagnostics all offered via an Internet portal or an interactive platform | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by H. Lundbeck A/S
- Other trademarks owned by Monsenso ApS
- Other trademarks owned by Monsenso ApS
- Other trademarks owned by Monsenso ApS
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named OURLOOP
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 21, 2026 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| May 2, 2026 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| May 2, 2026 | INPC | INVALIDATION PROCESSED | — |
| Oct 28, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 28, 2025 | C71T | CANCELLED SECTION 71 | — |
| Aug 14, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 21, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 4, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 4, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 14, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 14, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 1, 2018 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 29, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 29, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 25, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 16, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 16, 2018 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| May 9, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 9, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 9, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 20, 2018 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 13, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 10, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 9, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 9, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 13, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 13, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 13, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 12, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 12, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 12, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 12, 2018 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Feb 6, 2018 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jan 24, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 10, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 9, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 9, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 24, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 24, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 24, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 21, 2017 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Aug 8, 2017 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jul 24, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 24, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 24, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 24, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 24, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 14, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 14, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 7, 2017 | ALIE | ASSIGNED TO LIE | — |
| Jun 5, 2017 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 5, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 8, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 30, 2017 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Dec 30, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 30, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 27, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 26, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 23, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 19, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 19, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 15, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |